Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells

FEBS Letters

Volumn 586, Issue 10, 2012, Pages 1504-1509

  Yasukagawa, Tamami ^a   Niwa, Yuki ^a   Simizu, Siro ^a   Umezawa, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Glybenclamide; Ovarian cancer; Platelet derived growth factor; Potassium channel; Trafficking; Tumor invasion

Indexed keywords

GLIBENCLAMIDE; PAXILLINE; PLATELET DERIVED GROWTH FACTOR AA; POTASSIUM CHANNEL; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL STRAIN ES 2; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; OVARY CARCINOMA; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYBURIDE; HUMANS; OVARIAN NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; POTASSIUM CHANNEL BLOCKERS;

EID: 84861202114     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.04.007     Document Type: Article

References (34)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. C.H. Holoschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin. Surg. Oncol. 19 2000 3 10 (Pubitemid 30439309)
3. S.A. Cannistra Cancer of the ovary N. Engl. J. Med. 351 2004 2519 2529
4. D.R. Schwartz, S.L. Kardia, K.A. Shedden, R. Kuick, G. Michailidis, J.M. Taylor, D.E. Misek, R. Wu, Y. Zhai, D.M. Darrah, H. Reed, L.H. Ellenson, T.J. Giordano, E.R. Fearon, S.M. Hanash, and K.R. Cho Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas Cancer Res. 62 2002 4722 4729
5. E.L. Jenison, A.G. Montag, C.T. Griffiths, W.R. Welch, P.T. Lavin, J. Greer, and R.C. Knapp Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma Gynecol. Oncol. 32 1989 65 71 (Pubitemid 19029870)
6. T. Sugiyama, T. Kamura, J. Kigawa, N. Terakawa, Y. Kikuchi, T. Kita, M. Suzuki, I. Sato, and K. Taguchi Clinical characteristics of clear cell carcinoma of the ovary Cancer 88 2000 2584 2589
7. K. Behbakht, T.C. Randall, I. Benjamin, M.A. Morgan, S. King, and S.C. Rubin Clinical characteristics of clear cell carcinoma of the ovary Gynecol. Oncol. 70 1998 255 258 (Pubitemid 28430939)
8. North, R.A. (1995) Handbook of Receptors and Channels: Ligand- and Voltage-gated Ion Channels, CRC Press, Boca Raton, Florida.
9. K. Kunzelmann Ion channels and cancer J. Membr. Biol. 205 2005 159 173 (Pubitemid 41803693)
10. + channels in regulating tumour cell proliferation and apoptosis Pflügers Arch. 448 2004 274 286 (Pubitemid 40895596)
11. S.P. Fraser, J.K. Diss, A.M. Chioni, M.E. Mycielska, H. Pan, R.F. Yamaci, F. Pani, Z. Siwy, M. Krasowska, Z. Grzywna, W.J. Brackenbury, D. Theodorou, M. Koyutürk, H. Kaya, E. Battaloglu, M.T. De Bella, M.J. Slade, R. Tolhurst, C. Palmieri, J. Jiang, D.S. Latchman, R.C. Coombes, and M.B. Djamgoz Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis Clin. Cancer Res. 11 2005 5381 5389 (Pubitemid 41060811)
12. F.M. Ashcroft Adenosine 5′-triphosphate-sensitive potassium channels Annu. Rev. Neurosci. 11 1988 97 118
13. KATP: an inward rectifier subunit plus the sulfonylurea receptor Science 270 1995 1166 1170
14. ATP channel subunits Neuron 18 1997 827 838 (Pubitemid 27232792)
15. ATP channel complex J. Gen. Physiol. 110 1997 655 664 (Pubitemid 27524606)
16. H. Sakura, C. Ämmälä, P.A. Smith, F.M. Gribble, and F.M. Ashcroft Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle FEBS Lett. 377 1995 338 344 (Pubitemid 26025723)
17. L. Aguilar-Bryan, C.G. Nichols, S.W. Wechsler, J.P. Clement 4th, A.E. Boyd 3rd, G. González, H. Herrera-Sosa, K. Nguy, J. Bryan, and D.A. Nelson Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion Science 268 1995 423 426
18. N. Inagaki, Y. Tsuura, N. Namba, K. Masuda, T. Gonoi, M. Horie, Y. Seino, M. Mizuta, and S. Seino Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart J. Biol. Chem. 270 1995 5691 5694
19. + channels Neuron 16 1996 1011 1017 (Pubitemid 26171205)
20. F.M. Ashcroft, and P. Rorsman Electrophysiology of the pancreatic β-cell Prog. Biophys. Mol. Biol. 54 1989 87 143
21. S.J.H. Ashcroft, and F.M. Ashcroft The sulfonylurea receptor Biochem. Biophys. Acta 1175 1992 45 59 (Pubitemid 23014714)
22. + channels in the absence of the sulphonylurea receptor Nature 387 1997 179 183 (Pubitemid 27209432)
23. N. Miyanishi, Y. Suzuki, S. Simizu, Y. Kuwabara, K. Banno, and K. Umezawa Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion Biochem. Biophys. Res. Commun. 403 2010 154 159
24. I. Miyazaki, S. Simizu, H. Okumura, S. Takagi, and H. Osada A small-molecule inhibitor shows that pirin regulates migration of melanoma cells Nat. Chem. Biol. 6 2010 667 673
25. S. Simizu, T. Suzuki, M. Muroi, N.S. Lai, S. Takagi, N. Dohmae, and H. Osada Involvement of disulfide bond formation in the activation of heparanase Cancer Res. 67 2007 7841 7849 (Pubitemid 47281379)
26. + channel J. Biol. Chem. 271 1996 24321 24324 (Pubitemid 26333158)
27. + channel J. Physiol. 499 1997 715 720 (Pubitemid 27153593)
28. A. Ostman, and C.-H. Heldin Involvement of platelet-derived growth factor in disease: development of specific antagonists Adv. Cancer Res. 80 2001 1 38 (Pubitemid 33717320)
29. C.-H. Heldin, and B. Westermark Mechanism of action and in vivo role of platelet-derived growth factor Physiol. Rev. 79 1999 1283 1316 (Pubitemid 29473317)
30. C.E. Hart, J.W. Forstrom, J.D. Kelly, R.A. Seifert, R.A. Smith, R. Ross, M.J. Murray, and D.F. Bowen-Pope Two classes of PDGF receptor recognize different isoforms of PDGF Science 240 1988 1529 1531
31. C.-H. Heldin, A. Oëstman, and L. Rönnstrand Signal transduction via platelet-derived growth factor receptors Biochim. Biophys. Acta 1378 1998 F79 F113
32. D. Maitei, R.E. Emerson, Y.-C. Lai, L.A. Baldridge, J. Rao, C. Yiannoutsos, and D.B. Donner Autocrine activation of PDGFRα promotes the progression of ovarian cancer Oncogene 25 2006 2060 2069
33. WHO model list of essential medicines, 17th list, 2011.
34. F.M. Gribble, and F. Reimann Sulphonylurea action revisited: the post-cloning era Diabetologia 46 2003 875 891 (Pubitemid 36961311)